By exposing human first-trimester trophoblasts to obesity-related plasma factors, we demonstrate that insulin has a direct effect on the regulation of ID2 levels, suggesting that the adverse effects of maternal obesity on preeclampsia begin at an early stage of placental development. The gene discussed is ID2; the disease is obesity disorder.